Page last updated: 2024-10-24

cefuroxime and Shock, Cardiogenic

cefuroxime has been researched along with Shock, Cardiogenic in 1 studies

Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.

Shock, Cardiogenic: Shock resulting from diminution of cardiac output in heart disease.

Research Excerpts

ExcerptRelevanceReference
"The three reported variants of Kounis syndrome are vasospastic allergic angina, allergic myocardial infarction and stent thrombosis with occluding thrombus."2.58Coronary spasm secondary to cefuroxime injection, complicated with cardiogenic shock - a manifestation of Kounis syndrome: case report and literature review. ( Christodoulou, E; Georgiou, P; Mitsis, A, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mitsis, A1
Christodoulou, E1
Georgiou, P1

Reviews

1 review available for cefuroxime and Shock, Cardiogenic

ArticleYear
Coronary spasm secondary to cefuroxime injection, complicated with cardiogenic shock - a manifestation of Kounis syndrome: case report and literature review.
    European heart journal. Acute cardiovascular care, 2018, Volume: 7, Issue:7

    Topics: Anti-Bacterial Agents; Cefuroxime; Coronary Angiography; Coronary Vasospasm; Diagnosis, Differential

2018